Skip to main content
. 2023 Feb 3;14(4):614–622. doi: 10.1111/jdi.13977

Table 2.

The pregnancy outcomes of the study participants in gestational diabetes mellitus and NGT groups with singleton pregnancies

Gestational diabetes mellitus (n = 878) NGT (n = 825) P value
Insulin use, n (%) 213 (24.3) 1 (0.12) 0.02
Gestational weight gain, kg 7.4 ± 5.0 9.6 ± 4.7 <0.001
Gestational week, week 38.4 ± 1.8 38.7 ± 1.6 <0.001
Preterm birth, n (%) 77 (8.8) 47 (5.7) 0.02
Mode of delivery
Vaginal 433 (49.4) 419 (50.9) 0.34
Suction 95 (10.8) 101 (12.3)
Forceps 24 (2.7) 20 (2.4)
Scheduled cesarean section 160 (18.3) 149 (18.1)
Emergency cesarean section 158 (18.0) 136 (16.5)
Others 6 (0.69) 0 (0.0)
Neonatal death, n (%) 3 (0.34) 2 (0.24) 1.00
Sex (women), n (%) 413 (47.0) 406 (49.2) 0.38
High, cm 48.9 ± 2.8 49.3 ± 2.4 <0.001
Birth weight, g 2992.7 ± 480.0 3039.7 ± 442.8 0.03
Small‐for‐gestational age, n (%) 69 (7.9) 48 (5.8) 0.10
Large‐for‐gestational age, n (%) 140 (16.0) 131 (15.9) 0.98
Macrosomia, n (%) 10 (1.1) 13 (1.6) 0.43
Low‐birth‐weight, n (%) 107 (12.2) 69 (8.4) 0.01
Hypertensive disorders of pregnancy, n (%) 69 (9.7) 57 (6.9) 0.45
Placental abruption, n (%) 6 (0.69) 4 (0.49) 0.59
HELLP syndrome, n (%) 3 (0.34) 3 (0.36) 1.00
Maternal death, n (%) 0 (0.0) 0 (0.0)
Neonatal morphological abnormality, n (%) 50 (5.9) 32 (3.9) 0.06
NICU admission, n (%) 118 (17.0) 77 (12.8) 0.04
Apgar score 1 ≥ 7, n (%) 816 (93.3) 770 (93.3) 0.96
Apgar score 5 ≥ 7, n (%) 859 (98.1) 810 (98.2) 0.86
Shoulder dystocia, n (%) 3 (0.34) 1 (0.12) 0.63
Neonatal hypoglycemia, n (%) 11 (1.3) 2 (0.24) 0.02
Intravenous glucose administration (%) 25 (2.9) 14 (1.7) 0.11
Fracture, n (%) 0 (0.0) 0 (0.0)
Nerve plexus paralysis, n (%) 0 (0.0) 0 (0.0)

Data are mean (SD), or n (%).

HELLP, hemolytic anemia elevated liver enzymes low platelet count; NGT, normal glucose tolerance; NICU, neonatal intensive care unit.